Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May:(2):114-120.

[Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]

[Article in Russian]
Affiliations
  • PMID: 29901305
Review

[Extract of Serenoa repens in the treatment of benign prostatic hyperplasia and lower urinary tract symptoms]

[Article in Russian]
R E Amdii et al. Urologiia. 2018 May.

Abstract

This literature review focuses on the use of Serenoa repens extracts in the treatment of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Extracts of Serenoa repens produce marked anti-inflammatory, anti-androgenic and antiproliferative effects. Various extracts differ in their activity depending on the concentration of free fatty acids and the method of extract preparation. Extracts of Serenoa Repens from different manufacturers vary considerably in composition, effectiveness and supporting evidence. Evaluation of the effectiveness of Serenoa Repens extracts should be carried out for each extract separately, depending on the method of preparation and brand. The most studied and clinically effective is the hexane lipidosterol extract of Serenoa Repens Permixon. This assessment is supported by a report on Serenoa Repens, issued by the European Medicines Agency. In this report, only Serenoa repens hexanic extract Permixon is considered to be a well-established medical use product for the symptomatic treatment of BPH.

Keywords: Permixon; Serenoa repens; benign prostatic hyperplasia; lower urinary tract symptoms.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources